Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery.
Sirogen™ is currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes in patients requiring an arteriovenous fistula for hemodialysis.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 105 Union Avenue, Cresskill,nj 07626,united States
- Phone
- (201) 266-8310
- in****@****rtx.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- vasculartx.com
- HQ
- Cresskill, NJ
Vascular Therapies Questions
Vascular Therapies's helpline number is (201) 266-8310
Vascular Therapies's website is vasculartx.com
Vascular Therapies's LinkedIn profile is https://www.linkedin.com/company/vascular-therapies
Vascular Therapies has
5 employees.
View email and phone details for 5
employees at Vascular Therapies.
Vascular Therapies's industry is
Pharmaceutical Manufacturing
Vascular Therapies's top competitors are
Vascular Graft Solutions,
Rocket Pharmaceuticals,
Caeli Vascular, Inc.,
Vascular Disease Management,
Vascular Technology,
Allvivo Vascular, Inc.,
Vascular Art ( Advanced Revascularization Technologies),
Tharimmue,
Vascular & Vein Institute Of The South,
Vascular Flow Technologies Ltd.
Vascular Therapies's support email address is info@vasculartx.com
Vascular Therapies's categories are Pharmaceutical Manufacturing
Vascular Therapies's founding year is 2001
